The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Changes in Albuminuria and Subsequent Risk of Incident Kidney Disease
Open accessAbstract
Background and objectives: Albuminuria is a robust predictor of CKD progression. However, little is known about the associations of changes in albuminuria with the risk of kidney events outside the settings of clinical trials. Design, setting, participants, & measurements: In a nationwide cohort of 56,946 United States veterans with an eGFR≥60 ml/min per 1.73 m 2 , we examined the associations of 1-year fold changes in albuminuria with subsequent incident CKD (>25% decrease in eGFR reaching <60 ml/min per 1.73 m 2 ) and rapid eGFR decline (eGFR slope <−5 ml/min per 1.73 m 2 per year) assessed using Cox models and logistic regression, respectively, with adjustment for confounders. Results: The mean age was 64 (SD, 10) years old; 97% were men, and 91% were diabetic. There was a nearly linear association between 1-year fold changes in albuminuria and incident CKD. The multivariable-adjusted hazard ratios (95% confidence intervals) of incident CKD associated with more than twofold decrease, 1.25- to twofold decrease, 1.25- to twofold increase, and more than twofold increase (versus <1.25-fold decrease to <1.25-fold increase) in albuminuria were 0.82 (95% confidence interval, 0.77 to 0.89), 0.93 (95% confidence interval, 0.86 to 1.00), 1.12 (95% confidence interval, 1.05 to 1.20), and 1.29 (95% confidence interval, 1.21 to 1.38), respectively. Qualitatively similar associations were present for rapid eGFR decline (adjusted odds ratios; 95% confidence intervals for corresponding albuminuria changes: adjusted odds ratio, 0.86; 95% confidence interval, 0.78 to 0.94; adjusted odds ratio, 0.98; 95% confidence interval, 0.89 to 1.07; adjusted odds ratio, 1.18; 95% confidence interval, 1.08 to 1.29; and adjusted odds ratio, 1.67; 95% confidence interval, 1.54 and 1.81, respectively). Conclusions: Relative changes in albuminuria over a 1-year interval were linearly associated with subsequent risk of kidney outcomes. Additional studies are warranted to elucidate the underlying mechanisms of the observed associations and test whether active interventions to lower elevated albuminuria can improve kidney outcomes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In type 1 diabetes, remission of albuminuria may occur spontaneously, and cohort studies evaluating associations of change in albuminuria with clinical outcomes have reported inconsistent results (43,44).”
From 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2025 (2025) · cites this paper as [44]
In the citing paper
“In type 1 diabetes, remission of albuminuria may occur spontaneously, and cohort studies evaluating associations of change in albuminuria with clinical outcomes have reported inconsistent results (43,44).”
From 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2025 (2025) · cites this paper as [44]
In the citing paper
“Remission of albuminuria may occur spontaneously, and cohort studies evaluating associations of change in albuminuria with clinical outcomes have overall reported cardiovascular and kidney outcome benefits (9,45,46).”
From 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2026 (2026) · cites this paper as [46]
Citations
Cites
KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease
Stevens, P. E., Ahmed, S. B., Carrero, J. J., Foster, B., Francis, A., Hall, R. K., Herrington, W. G., Hill, G., Inker, L. A., Kazancıoğlu, R., et al. (2024) · Kidney International · doi:10.1016/j.kint.2023.10.018 · Cited by 8,530
Stevens, P. E., Levin, A., & for the Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members* (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-11-201306040-00007 · Cited by 3,607
(2013) · Kidney International Supplements · doi:10.1038/kisup.2012.73 · Cited by 3,206
Gerstein, H. C. (2001) · JAMA · doi:10.1001/jama.286.4.421 · Cited by 2,440
Hillege, H. L., Fidler, V., Diercks, G. F. H., van Gilst, W. H., de Zeeuw, D., van Veldhuisen, D. J., Gans, R. O. B., Janssen, W. M. T., Grobbee, D. E., & de Jong, P. E. (2002) · Circulation · doi:10.1161/01.cir.0000031732.78052.81 · Cited by 1,551
Albuminuria reflects widespread vascular damage: The Steno hypothesis
Deckert, T., Feldt-Rasmussen, B., Borch-Johnsen, K., Jensen, T., & Kofoed-Enevoldsen, A. (1989) · Diabetologia · doi:10.1007/bf00285287 · Cited by 1,400
Relation Between Kidney Function, Proteinuria, and Adverse Outcomes
Hemmelgarn, B. R. (2010) · JAMA · doi:10.1001/jama.2010.39 · Cited by 1,041
Coresh, J., Turin, T. C., Matsushita, K., Sang, Y., Ballew, S. H., Appel, L. J., Arima, H., Chadban, S. J., Cirillo, M., Djurdjev, O., et al. (2014) · JAMA · doi:10.1001/jama.2014.6634 · Cited by 988 · cited 1×
“5 years after the first UACR measurement could be used for the 1-year fold change) (26).”
MethodSelf-citationAlbuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes
Ninomiya, T., Perkovic, V., de Galan, B. E., Zoungas, S., Pillai, A., Jardine, M., Patel, A., Cass, A., Neal, B., Poulter, N., et al. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008121270 · Cited by 965
Gansevoort, R. T., Matsushita, K., van der Velde, M., Astor, B. C., Woodward, M., Levey, A. S., de Jong, P. E., & Coresh, J. (2011) · Kidney International · doi:10.1038/ki.2010.531 · Cited by 883
The hyperfiltration theory: A paradigm shift in nephrology
Brenner, B. M., Lawler, E. V., & Mackenzie, H. S. (1996) · Kidney International · doi:10.1038/ki.1996.265 · Cited by 868
Levin, A., & Stevens, P. E. (2014) · Kidney International · doi:10.1038/ki.2013.444 · Cited by 845
Astor, B. C., the Chronic Kidney Disease Prognosis Consortium, Matsushita, K., Gansevoort, R. T., van der Velde, M., Woodward, M., Levey, A. S., Jong, P. E. D., & Coresh, J. (2011) · Kidney International · doi:10.1038/ki.2010.550 · Cited by 774
Klausen, K., Borch-Johnsen, K., Feldt-Rasmussen, B., Jensen, G., Clausen, P., Scharling, H., Appleyard, M., & Jensen, J. S. (2004) · Circulation · doi:10.1161/01.cir.0000133312.96477.48 · Cited by 693
Accuracy and completeness of mortality data in the Department of Veterans Affairs
Sohn, M.-W., Arnold, N., Maynard, C., & Hynes, D. M. (2006) · Population Health Metrics · doi:10.1186/1478-7954-4-2 · Cited by 542 · cited 1×
“Information about allcause mortality was obtained from the VA Vital Status Files (33).”
MethodRuggenenti, P., Nefrologia”(GISEN), O. B. O. T. “. I. D. S. E. I., Perna, A., Mosconi, L., Pisoni, R., & Remuzzi, G. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00874.x · Cited by 434
Zoja, C., Donadelli, R., Colleoni, S., Figliuzzi, M., Bonazzola, S., Morigi, M., & Remuzzi, G. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00905.x · Cited by 419
Measuring concurrent adherence to multiple related medications.
Choudhry, N. K., Shrank, W. H., Levin, R., Lee, J. L.-Y., Jan, S. A., Brookhart, M. A., & Solomon, D. H. (2009) · PubMed · Cited by 378
Renal Dysfunction Complicating the Treatment of Hypertension
Palmer, B. F. (2002) · New England Journal of Medicine · doi:10.1056/nejmra020676 · Cited by 326 · cited 1×
“, with nephropathy) accompanied by impaired glomerular autoregulation (44,45), for example, decreases in UACR may represent their decreased ability to adapt to lower kidney perfusion pressures (46), which could cause ischemic kidney injury.”
BackgroundRomundstad, S., Holmen, J., Kvenild, K., Hallan, H., & Ellekjær, H. (2003) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(03)00742-x · Cited by 270
Changes in Albuminuria Predict Mortality and Morbidity in Patients with Vascular Disease
Schmieder, R. E., Mann, J. F. E., Schumacher, H., Gao, P., Mancia, G., Weber, M. A., McQueen, M., Koon, T., & Yusuf, S. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010091001 · Cited by 270
Mogensen, C. E., Vestbo, E., Poulsen, P. L., Christianse, C., Damsgaar, E. M., Hans, E., Frøland, A., Hansen, K. W., Nielsen, S., & Pedersen, M. M. (1995) · Diabetes Care · doi:10.2337/diacare.18.4.572 · Cited by 243
Drug-Induced Reduction in Albuminuria Is Associated with Subsequent Renoprotection: A Meta-Analysis
Lambers Heerspink, H. J., Kröpelin, T. F., Hoekman, J., & de Zeeuw, D. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014070688 · Cited by 242
Blood Pressure and Mortality in U.S. Veterans With Chronic Kidney Disease: A Cohort Study
Kovesdy, C. P., Bleyer, A. J., Molnar, M. Z., Ma, J. Z., Sim, J. J., Cushman, W. C., Quarles, L. D., & Kalantar-Zadeh, K. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-4-201308200-00004 · Cited by 213
Self-citationWANG, Y., RANGAN, G. K., TAY, Y.-C., WANG, Y., & HARRIS, D. C. H. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1061204 · Cited by 208
Yuyun, M. F. (2004) · International Journal of Epidemiology · doi:10.1093/ije/dyh008 · Cited by 192
The glycocalyx—linking albuminuria with renal and cardiovascular disease
Rabelink, T. J., & de Zeeuw, D. (2015) · Nature Reviews Nephrology · doi:10.1038/nrneph.2015.162 · Cited by 178
Albuminuria Is an Appropriate Therapeutic Target in Patients with CKD: The Pro View
Lambers Heerspink, H. J., & Gansevoort, R. T. (2015) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.11511114 · Cited by 168
Proteinuria should be used as a surrogate in CKD
Cravedi, P., Ruggenenti, P. L., & Remuzzi, G. (2012) · Nature Reviews Nephrology · doi:10.1038/nrneph.2012.42 · Cited by 157
Sumida, K., Molnar, M. Z., Potukuchi, P. K., Thomas, F., Lü, J., Matsushita, K., Yamagata, K., Kalantar‐Zadeh, K., & Kovesdy, C. P. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016060656 · Cited by 156 · cited 1×
“The start of follow-up was the date of the last UACR measurement, and patients were censored at the time of death, the last encounter, or the last date of available kidney event (October 13, 2012 and September 13, 2011 for incident CKD and ESRD, respectively) (32).”
MethodSelf-citationAlbuminuria changes are associated with subsequent risk of end-stage renal disease and mortality
Carrero, J. J., Grams, M. E., Sang, Y., Ärnlöv, J., Gasparini, A., Matsushita, K., Qureshi, A. R., Evans, M., Barany, P. F., Lindholm, B., et al. (2016) · Kidney International · doi:10.1016/j.kint.2016.09.037 · Cited by 152 · cited 3×
“25- to twofold increase, and more than twofold increase (20).”
BackgroundResultAssociation of Race With Mortality and Cardiovascular Events in a Large Cohort of US Veterans
Kovesdy, C. P., Norris, K. C., Boulware, L. E., Lu, J. L., Ma, J. Z., Streja, E., Molnar, M. Z., & Kalantar‐Zadeh, K. (2015) · Circulation · doi:10.1161/circulationaha.114.015124 · Cited by 118
Self-citationImpaired autoregulation of GFR in hypertensive non-insulin dependent diabetic patients
Christensen, P. K., Hansen, H. P., & Parving, H. (1997) · Kidney International · doi:10.1038/ki.1997.463 · Cited by 117
Albuminuria changes and cardiovascular and renal outcomes in type 1 diabetes: the DCCT/EDIC study
de Boer, I. H., Gao, X., Cleary, P. A., Bebu, I., Lachin, J. M., Molitch, M. E., Orchard, T., Paterson, A. D., Perkins, B. A., Steffes, M. W., et al. (2016) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02870316 · Cited by 114
Activation of Mitogenic Pathways by Albumin in Kidney Proximal Tubule Epithelial Cells
Dixon, R. C., & Brunskill, N. J. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1071487 · Cited by 113
Leffondré, K., Boucquemont, J., Tripepi, G. L., Stel, V. S., Heinze, G., & Dunkler, D. (2014) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfu320 · Cited by 111 · cited 2×
“Additionally, the associations were examined using UACR slopes calculated by both ordinary least squares regression models and linear mixed effects models using all intraindividual UACR values (34).”
MethodKovesdy, C. P., Lü, J., Molnar, M. Z., Ma, J. Z., Canada, R. B., Streja, E., Kalantar‐Zadeh, K., & Bleyer, A. J. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.3279 · Cited by 98 · cited 2×
“Sociodemographic characteristics, comorbid conditions, laboratory characteristics, and medication use were obtained as previously described (27,28).”
BackgroundMethodSelf-citationOutcomes Associated With Microalbuminuria
Kovesdy, C. P., Lott, E. H., Lü, J., Malakauskas, S. M., Ma, J. Z., Molnar, M. Z., & Kalantar‐Zadeh, K. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.11.071 · Cited by 53
Self-citationGosmanova, E. O., Lü, J., Streja, E., Cushman, W. C., Kalantar‐Zadeh, K., & Kovesdy, C. P. (2014) · Hypertension · doi:10.1161/hypertensionaha.114.03805 · Cited by 52
Self-citationJensen, J. S. (1995) · Clinica Chimica Acta · doi:10.1016/0009-8981(95)06155-x · Cited by 49 · cited 1×
“Furthermore, the changes in urinary albumin-to-creatinine ratio (UACR) in previous studies were generally defined using a single first measurement and a single last measurement, which may be subject to potentially substantial intraindividual variability of albuminuria over time (22,23), and thus, may be less precise t…”
MethodAlbuminuria is Not an Appropriate Therapeutic Target in Patients with CKD: The Con View
Fried, L. F., & Lewis, J. B. (2015) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.10681014 · Cited by 48
Albumin Stimulates the Accumulation of Extracellular Matrix in Renal Tubular Epithelial Cells
Stéphan, J.-P., Mao, W., Filvaroff, E. H., Cai, L., Rabkin, R., & Pan, G. (2003) · American Journal of Nephrology · doi:10.1159/000075347 · Cited by 47
on behalf of the ONTARGET/TRANSCEND investigators, Schmieder, R. E., Schutte, R., Schumacher, H., Böhm, M., Mancia, G., Weber, M. A., McQueen, M., Teo, K. K., & Yusuf, S. (2014) · Diabetologia · doi:10.1007/s00125-014-3330-9 · Cited by 45
Microalbuminuria in diabetes mellitus—is there a structural basis?
Østerby, R. (1995) · Nephrology Dialysis Transplantation · doi:10.1093/oxfordjournals.ndt.a090826 · Cited by 43
Association of Increasing GFR with Change in Albuminuria in the General Population
Melsom, T., Stefansson, V. T. N., Schei, J., Solbu, M. D., Jenssen, T. G., Wilsgaard, T., & Eriksen, B. O. (2016) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04940516 · Cited by 40
Proteinuria as a surrogate end point—more data are needed
Thompson, A. (2012) · Nature Reviews Nephrology · doi:10.1038/nrneph.2012.43 · Cited by 39
Romundstad, S., Hatlen, G., & Hallan, S. I. (2016) · Journal of Hypertension · doi:10.1097/hjh.0000000000001035 · Cited by 5 · cited 1×
“It is also important to note that similar associations have been reported between decreases in UACR and cardiovascular events or mortality in different patient populations (21,47), and very low UACR levels have been associated with higher mortality and poorer kidney outcomes in patients with advanced CKD (48).”
Background
Cited by
11. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes−2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s011 · Cited by 460
11. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes—2019
American Diabetes Association (2019) · Diabetes Care · doi:10.2337/dc19-s011 · Cited by 398
11. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s011 · Cited by 395
“In type 1 diabetes, remission of albuminuria may occur spontaneously, and cohort studies evaluating associations of change in albuminuria with clinical outcomes have reported inconsistent results (40,41).”
Result11. Chronic Kidney Disease and Risk Management: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s011 · Cited by 344
Coresh, J., Heerspink, H. J. L., Sang, Y., Matsushita, K., Arnlov, J., Astor, B. C., Black, C., Brunskill, N. J., Carrero, J.-J., Feldman, H. I., et al. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30313-9 · Cited by 338
Self-citation
Metadata
- Authors
- Sumida, K., Molnar, M. Z., Potukuchi, P. K., George, K., Thomas, F., Lu, J. L., Yamagata, K., Kalantar-Zadeh, K., & Kovesdy, C. P.
- Affiliations
- University of Tsukuba (JP)
- Semmelweis University (HU)
- Division of Nephrology, Department of Medicine and
- University of Tennessee Health Science Center (US)
- Harold Simmons Center for Chronic Disease Research and Epidemiology, Division of Nephrology and Hypertension, University of California, Irvine, Orange, California; and
- Memphis VA Medical Center (US)
- Corresponding author
- Sumida, Keiichi
- Molnar, Miklos Z.
- Potukuchi, Praveen K.
- George, Koshy
- Kovesdy, Csaba P.
- ORCID
- Venue
- Clinical Journal of the American Society of Nephrology
- Published
- 2017-09-11
- Volume
- 12
- Issue
- 12
- Pages
- 1941-1949
- ISSN
- 1555-9041 (ISSN-L)
- 1555-905X
- PMC
- PMC5718265
- OpenAlex
- W2754503059
- Semantic Scholar
- d1856de616ff5926002002f9513294fe6cb26c8e
- Cited by
- 47
- References
- 48
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 1 · 2023: 3 · 2022: 4 · 2021: 7 · 2020: 7 · 2019: 12 · 2018: 7 · 2017: 1
- FWCI
- 6.61
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Clinical Journal of the American Society of Nephrology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Funders
- U.S. Department of Veterans Affairs (SDR 02-237)
- Office of Research and Development
- Health Services Research and Development
- National Institutes of Health
- Centers for Medicare and Medicaid Services
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK096920)
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
- Health Sciences › Medicine › Nephrology › Renal Diseases and Glomerulopathies
- Keywords
- albuminuria, chronic kidney disease, estimated glomerular filtration rate decline, diabetic nephropathy, renal outcomes
- MeSH terms
- Aged, Albuminuria, Creatinine, Female, Glomerular Filtration Rate, Humans, Male, Middle Aged, Retrospective Studies, Risk Factors, United States, Incidence, Renal Insufficiency, Chronic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.